ID

39031

Description

Testing the Effect of the InsuPad Device in Daily Life Conditions; ODM derived from: https://clinicaltrials.gov/show/NCT01594801

Lien

https://clinicaltrials.gov/show/NCT01594801

Mots-clés

Versions (1)
  1. 22/11/2019 22/11/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

22 novembre 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

Aucun commentaire

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Diabetics Mellitus Type 1 NCT01594801

Anglais

Eligibility Diabetics Mellitus Type 1 NCT01594801

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female subjects aged 18 to 75 years (including 18 and 75 years old).
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
type 1 or type 2 diabetes mellitus subjects with daily short-acting prandial insulin intake of > 60 iu/day.
Description

Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus, Non-Insulin-Dependent | Short-Acting Insulin Mealtime IU/day

Type de données

boolean

Alias
UMLS CUI [1]
C0011854
UMLS CUI [2]
C0011860
UMLS CUI [3,1]
C0356365
UMLS CUI [3,2]
C0587119
UMLS CUI [3,3]
C0439465
hba1c >=6.0% and =< 8%
Description

Hemoglobin A1c measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0474680
use of short-acting prandial insulin analogues with multiple daily injections. the analog insulin brands to be used will be either insulin lispro (humalog, liprolog) or insulin aspart (novorapid) or insulin glulisin (apidra).
Description

Short-Acting Insulin Analogue Mealtime | Injection multiple Daily | Insulin Lispro | Humalog | Insulin Aspart | NovoLog | Insulin Glulisine | Apidra

Type de données

boolean

Alias
UMLS CUI [1,1]
C0356365
UMLS CUI [1,2]
C0243071
UMLS CUI [1,3]
C0587119
UMLS CUI [2,1]
C1533685
UMLS CUI [2,2]
C0439064
UMLS CUI [2,3]
C0332173
UMLS CUI [3]
C0293359
UMLS CUI [4]
C0528249
UMLS CUI [5]
C1708521
UMLS CUI [6]
C0939412
UMLS CUI [7]
C1313386
UMLS CUI [8]
C1654827
subject agrees to sign consent form before any study-specific tests or procedures are to be performed.
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
study subject is willing to perform at least 5 blood glucose measurements per day for at least 3 months, willing to comply with study procedures and to keep a detailed patient log book.
Description

Blood glucose measurement times/day | Protocol Compliance | Subject Diary

Type de données

boolean

Alias
UMLS CUI [1,1]
C0392201
UMLS CUI [1,2]
C0439511
UMLS CUI [2]
C0525058
UMLS CUI [3]
C3890583
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
excessive fibrosis, lipo-hypertrophy or eczema at injection sites.
Description

Fibrosis Excessive | Lipohypertrophy | Eczema Injection site

Type de données

boolean

Alias
UMLS CUI [1,1]
C0016059
UMLS CUI [1,2]
C0442802
UMLS CUI [2]
C1262113
UMLS CUI [3,1]
C0013595
UMLS CUI [3,2]
C2700396
known gastro- or enteroparesis.
Description

Gastroparesis | Enteroparesis

Type de données

boolean

Alias
UMLS CUI [1]
C0152020
UMLS CUI [2]
C1328465
unstable chronic disease other than diabetes mellitus (e. g. unstable angina pectoris, renal disease) for the last six months before study start.
Description

Chronic disease Unstable | Exception Diabetes Mellitus | Angina, Unstable | Kidney Disease

Type de données

boolean

Alias
UMLS CUI [1,1]
C0008679
UMLS CUI [1,2]
C0443343
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0011849
UMLS CUI [3]
C0002965
UMLS CUI [4]
C0022658
severe hypoglycaemic events requiring glucagon injection or glucose infusion within the last four weeks prior to study start.
Description

Hypoglycaemic episode Severe | Requirement Glucagon Injection | Requirement Glucose Infusion

Type de données

boolean

Alias
UMLS CUI [1,1]
C0745153
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C1514873
UMLS CUI [2,2]
C4026725
UMLS CUI [3,1]
C1514873
UMLS CUI [3,2]
C0017725
UMLS CUI [3,3]
C0574032
hypoglycaemia unawareness (score > 4 in the hypoglycaemia awareness questionnaire)
Description

Loss of hypoglycemic warning | Hypoglycemia Awareness Questionnaire Score

Type de données

boolean

Alias
UMLS CUI [1]
C0342317
UMLS CUI [2,1]
C0020615
UMLS CUI [2,2]
C0004448
UMLS CUI [2,3]
C0034394
UMLS CUI [2,4]
C0449820
diabetic ketoacidosis (severe, with hospitalization) within the last six months prior to study start
Description

Diabetic Ketoacidosis Severe | Hospitalization

Type de données

boolean

Alias
UMLS CUI [1,1]
C0011880
UMLS CUI [1,2]
C0205082
UMLS CUI [2]
C0019993
any known life-threatening disease
Description

Life threatening illness

Type de données

boolean

Alias
UMLS CUI [1]
C3846017
pregnant women, lactating women or women who intend to become pregnant during the observation period
Description

Pregnancy | Breast Feeding | Pregnancy intended

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3,1]
C0032961
UMLS CUI [3,2]
C1283828
any other condition or compliance issues that might interfere with study participation or results
Description

Condition Interferes with Study Subject Participation Status | Compliance problem Interferes with Study Subject Participation Status | Condition Interferes with Research results | Compliance problem Interferes with Research results

Type de données

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C2348568
UMLS CUI [2,1]
C0848919
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C2348568
UMLS CUI [3,1]
C0348080
UMLS CUI [3,2]
C0521102
UMLS CUI [3,3]
C0683954
UMLS CUI [4,1]
C0848919
UMLS CUI [4,2]
C0521102
UMLS CUI [4,3]
C0683954
subjects with heat sensitivity
Description

Heat sensitivity

Type de données

boolean

Alias
UMLS CUI [1]
C0231274
subjects involved in or planned to participate in other studies
Description

Study Subject Participation Status | Clinical Trials | Clinical Trials Planned

Type de données

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0008976
UMLS CUI [3,1]
C0008976
UMLS CUI [3,2]
C1301732
subjects who are incapable of contracting or under guardianship
Description

Contracting incapable | Patients Guardianship

Type de données

boolean

Alias
UMLS CUI [1,1]
C0332522
UMLS CUI [1,2]
C1550518
UMLS CUI [2,1]
C0030705
UMLS CUI [2,2]
C0870627
Retour au début de la page

Similar models

Eligibility Diabetics Mellitus Type 1 NCT01594801

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
male or female subjects aged 18 to 75 years (including 18 and 75 years old).
boolean
C0001779 (UMLS CUI [1])
Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus, Non-Insulin-Dependent | Short-Acting Insulin Mealtime IU/day
Item
type 1 or type 2 diabetes mellitus subjects with daily short-acting prandial insulin intake of > 60 iu/day.
boolean
C0011854 (UMLS CUI [1])
C0011860 (UMLS CUI [2])
C0356365 (UMLS CUI [3,1])
C0587119 (UMLS CUI [3,2])
C0439465 (UMLS CUI [3,3])
Hemoglobin A1c measurement
Item
hba1c >=6.0% and =< 8%
boolean
C0474680 (UMLS CUI [1])
Short-Acting Insulin Analogue Mealtime | Injection multiple Daily | Insulin Lispro | Humalog | Insulin Aspart | NovoLog | Insulin Glulisine | Apidra
Item
use of short-acting prandial insulin analogues with multiple daily injections. the analog insulin brands to be used will be either insulin lispro (humalog, liprolog) or insulin aspart (novorapid) or insulin glulisin (apidra).
boolean
C0356365 (UMLS CUI [1,1])
C0243071 (UMLS CUI [1,2])
C0587119 (UMLS CUI [1,3])
C1533685 (UMLS CUI [2,1])
C0439064 (UMLS CUI [2,2])
C0332173 (UMLS CUI [2,3])
C0293359 (UMLS CUI [3])
C0528249 (UMLS CUI [4])
C1708521 (UMLS CUI [5])
C0939412 (UMLS CUI [6])
C1313386 (UMLS CUI [7])
C1654827 (UMLS CUI [8])
Informed Consent
Item
subject agrees to sign consent form before any study-specific tests or procedures are to be performed.
boolean
C0021430 (UMLS CUI [1])
Blood glucose measurement times/day | Protocol Compliance | Subject Diary
Item
study subject is willing to perform at least 5 blood glucose measurements per day for at least 3 months, willing to comply with study procedures and to keep a detailed patient log book.
boolean
C0392201 (UMLS CUI [1,1])
C0439511 (UMLS CUI [1,2])
C0525058 (UMLS CUI [2])
C3890583 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Fibrosis Excessive | Lipohypertrophy | Eczema Injection site
Item
excessive fibrosis, lipo-hypertrophy or eczema at injection sites.
boolean
C0016059 (UMLS CUI [1,1])
C0442802 (UMLS CUI [1,2])
C1262113 (UMLS CUI [2])
C0013595 (UMLS CUI [3,1])
C2700396 (UMLS CUI [3,2])
Gastroparesis | Enteroparesis
Item
known gastro- or enteroparesis.
boolean
C0152020 (UMLS CUI [1])
C1328465 (UMLS CUI [2])
Chronic disease Unstable | Exception Diabetes Mellitus | Angina, Unstable | Kidney Disease
Item
unstable chronic disease other than diabetes mellitus (e. g. unstable angina pectoris, renal disease) for the last six months before study start.
boolean
C0008679 (UMLS CUI [1,1])
C0443343 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0011849 (UMLS CUI [2,2])
C0002965 (UMLS CUI [3])
C0022658 (UMLS CUI [4])
Hypoglycaemic episode Severe | Requirement Glucagon Injection | Requirement Glucose Infusion
Item
severe hypoglycaemic events requiring glucagon injection or glucose infusion within the last four weeks prior to study start.
boolean
C0745153 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C1514873 (UMLS CUI [2,1])
C4026725 (UMLS CUI [2,2])
C1514873 (UMLS CUI [3,1])
C0017725 (UMLS CUI [3,2])
C0574032 (UMLS CUI [3,3])
Loss of hypoglycemic warning | Hypoglycemia Awareness Questionnaire Score
Item
hypoglycaemia unawareness (score > 4 in the hypoglycaemia awareness questionnaire)
boolean
C0342317 (UMLS CUI [1])
C0020615 (UMLS CUI [2,1])
C0004448 (UMLS CUI [2,2])
C0034394 (UMLS CUI [2,3])
C0449820 (UMLS CUI [2,4])
Diabetic Ketoacidosis Severe | Hospitalization
Item
diabetic ketoacidosis (severe, with hospitalization) within the last six months prior to study start
boolean
C0011880 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0019993 (UMLS CUI [2])
Life threatening illness
Item
any known life-threatening disease
boolean
C3846017 (UMLS CUI [1])
Pregnancy | Breast Feeding | Pregnancy intended
Item
pregnant women, lactating women or women who intend to become pregnant during the observation period
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032961 (UMLS CUI [3,1])
C1283828 (UMLS CUI [3,2])
Condition Interferes with Study Subject Participation Status | Compliance problem Interferes with Study Subject Participation Status | Condition Interferes with Research results | Compliance problem Interferes with Research results
Item
any other condition or compliance issues that might interfere with study participation or results
boolean
C0348080 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C0848919 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C2348568 (UMLS CUI [2,3])
C0348080 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C0683954 (UMLS CUI [3,3])
C0848919 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C0683954 (UMLS CUI [4,3])
Heat sensitivity
Item
subjects with heat sensitivity
boolean
C0231274 (UMLS CUI [1])
Study Subject Participation Status | Clinical Trials | Clinical Trials Planned
Item
subjects involved in or planned to participate in other studies
boolean
C2348568 (UMLS CUI [1])
C0008976 (UMLS CUI [2])
C0008976 (UMLS CUI [3,1])
C1301732 (UMLS CUI [3,2])
Contracting incapable | Patients Guardianship
Item
subjects who are incapable of contracting or under guardianship
boolean
C0332522 (UMLS CUI [1,1])
C1550518 (UMLS CUI [1,2])
C0030705 (UMLS CUI [2,1])
C0870627 (UMLS CUI [2,2])
Retour au début de la page 

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial